topics experimental-use-exception 
SpicyIP
JUNE 19, 2022
The IP Reveries series is an experimental ‘fun’ series set in an imaginary classroom where we are using a dialogue format to raise questions and discussions around IP that traditionally don’t find a place to get voiced either due to long standing assumptions, or due to being seen as ‘too trivial’ to discuss in more formal settings.
Velocity of Content
SEPTEMBER 22, 2022
And little bit of updated information on the topics we covered: * Psychology, in particular, seems to have a replicability problem ; even outside of psych, everyone knows that bad papers are still getting published (and they may even have a discoverability advantage ).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
LexBlog IP
AUGUST 28, 2023
Specifically, enablement requires a patent specification to contain sufficient information regarding the subject matter of the claims so as to “enable” a person skilled in the art to make and use the claimed invention. This topic was recently previewed in Realtime Data v. The more one claims, the more one must enable.
SpicyIP
JULY 3, 2022
The IP Reveries series is an experimental ‘fun’ series set in an imaginary classroom where we are using a dialogue format to raise questions and discussions around IP that traditionally don’t find a place to get voiced either due to long standing assumptions, or due to being seen as ‘too trivial’ to discuss in more formal settings.
The IPKat
OCTOBER 25, 2021
As expected, the Board of Appeal in T 116/18 has now referred to the Enlarged Board of Appeal (EBA) questions on the use of post-filed evidence to establish plausibility for an invention. The referral (G2/12) is confirmed in the Board of Appeal's decision in T 116/18 and is also summarised in an EPO press release ( here ).
Velocity of Content
MARCH 26, 2024
Members of the Ontologies Team have previously held pivotal roles in the development and maintenance of essential resources like the Gene Ontology (GO), Experimental Factor Ontology (EFO), Cell Ontology, UniProt, and ChEMBL. AI is the topic on everyone’s minds, and we know it brings tremendous potential to the life sciences industry.
Fish & Richardson Trademark & Copyright Thoughts
JANUARY 11, 2022
The agencies committed to “take appropriate steps to address companies making false or misleading communications about biologics, including biosimilars and interchangeable products, which will help deter anti-competitive behavior in the biologics market and can help lead to the use of all available biological products.”
Expert insights. Personalized for you.
119 
Let's personalize your content